Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MECHLORETHAMINE for Cutaneous t-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 738 adverse event reports in the FDA FAERS database where MECHLORETHAMINE was used for Cutaneous t-cell lymphoma.

Most Reported Side Effects for MECHLORETHAMINE

Side Effect Reports % Deaths Hosp.
Pruritus 317 12.3% 1 19
Application site pruritus 227 8.8% 0 10
Application site erythema 222 8.6% 1 15
Application site pain 217 8.4% 2 8
Erythema 210 8.1% 1 13
Off label use 207 8.0% 17 27
Condition aggravated 197 7.6% 2 20
Skin discolouration 147 5.7% 0 7
Rash 130 5.0% 1 9
Skin irritation 114 4.4% 2 5
Blister 107 4.2% 0 9
Disease progression 107 4.2% 8 13
Application site irritation 103 4.0% 0 6
Application site discolouration 101 3.9% 1 2
Drug ineffective 100 3.9% 1 2

Other Indications for MECHLORETHAMINE

Mycosis fungoides (1,398) Hodgkin's disease (228) Product used for unknown indication (37) Cutaneous t-cell lymphoma stage i (34) Cutaneous t-cell lymphoma stage ii (13) Hodgkin's disease stage iii (9) Langerhans' cell histiocytosis (9) Mycosis fungoides stage i (9) Occupational exposure to product (9) Neuroblastoma (8)

Other Drugs Used for Cutaneous t-cell lymphoma

MOGAMULIZUMAB-KPKC (589) BRENTUXIMAB VEDOTIN (314) BEXAROTENE (266) DOXORUBICIN (163) GEMCITABINE (163) METHOTREXATE (149) CYCLOPHOSPHAMIDE (131) PREDNISONE (105) VINCRISTINE (105) ROMIDEPSIN (101)

Related Pages

MECHLORETHAMINE Full Profile All Cutaneous t-cell lymphoma Drugs MECHLORETHAMINE Demographics MECHLORETHAMINE Timeline